Neurotransmitter transporter (NTT) (NTT)

Neurotransmitter transporters are a group of membrane-bound proteins responsible for the termination of synaptic signaling by facilitating the reabsorption, or reuptake, of neurotransmitters from the synaptic cleft into the presynaptic neuron or adjacent glial cells [1, 8, 15]. This process is vital for maintaining synaptic homeostasis, recycling chemical messengers for future release, and preventing the overstimulation of postsynaptic receptors [2, 10, 14]. These transporters primarily belong to the solute carrier (SLC) families, such as SLC1 (glutamate transporters) and SLC6 (monoamine and GABA transporters), utilizing ion gradients to drive the transport of molecules against their concentration gradients [2, 4, 8]. Dysregulation of neurotransmitter reuptake is a central feature in the pathophysiology of many psychiatric and neurological conditions, including major depression, ADHD, and epilepsy [4, 7, 12]. Consequently, these transporters serve as major therapeutic targets for drug classes such as selective serotonin reuptake inhibitors (SSRIs), which increase neurotransmitter availability to improve mood and cognition [11, 13, 16]. However, modulating these systems can present challenges, including risks of serotonin syndrome, cardiovascular strain, and withdrawal symptoms upon cessation [11, 14].

Other names

Neurotransmitter reuptakeNeurotransmitter reuptake proteinReuptake transporterNeurotransmitter uptake systemReuptake pumpPlasma membrane neurotransmitter transporter

Reuptake inhibition, competitive inhibition of transport, and substrate-induced reverse transport.